This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Biosimilars In Emerging Economies - Advanced Recombinant Technology Platforms And Low Cost Manufacturing Put India And China At A Strategic Advantage In Biosimilar Production

10.1 Mergers and Acquisitions 74

10.1.1 M&A by Year 74

10.1.2 M&A by Value 75

10.1.3 M&A by Type 75

10.1.4 M&A Deals 76

10.2 Licensing Agreements 78

10.3 Co-developments 80

11 Biosimilars in Emerging Economies – Appendix 82

11.1 Market Definitions 82

11.2 Abbreviations 82

11.3 Bibliography 84

11.4 Research Methodology 86

11.4.1 Market Overview 87

11.4.2 Market Characterization 87

11.4.3 India 87

11.4.4 China 87

11.4.5 Other Emerging Economies 87

11.4.6 Pipeline Analysis 88

11.4.7 Industry Dynamics 88

11.4.8 Deals Analysis 88

11.5 Contact Us 88

11.6 Disclaimer 88

 

 

 

List of Tables

 

Table 1: Biosimilars in Emerging Economies, Key Patent Expiries of Leading Biologics From 2011–2018 23

Table 2: Biosimilars in Emerging Economies, Revenue ($bn), 2002–2011 24

Table 3: Biosimilars in Emerging Economies, Revenue Forecasts ($bn), 2011–2018 24

Table 4: Biosimilars in Emerging Economies, Marketed Biosimilar Products, India, 2012 25

Table 5: Biosimilars in Emerging Economies, Marketed Biosimilar Products, China, 2012 26

Table 6: Biosimilars in Emerging Economies, Marketed Biosimilar Products, Other Emerging Economies, 2012 27

Table 7: Biosimilars in Emerging Economies, India, Revenue ($bn), 2002–2011 28

Table 8: Biosimilars in Emerging Economies, India, Revenue Forecasts ($bn), 2011–2018 28

Table 9: Biosimilars in Emerging Economies, Marketed Biosimilar Products, Dr. Reddy's, 2012 31

Table 10: Biosimilars in Emerging Economies, Marketed Biosimilar Products, Biocon, 2012 33

Table 11: Biosimilars in Emerging Economies, Pipeline Molecules, Biocon, 2012 33

Table 12: Biosimilars in Emerging Economies, Marketed Biosimilar Products, IBPL, 2012 34

Table 13: Biosimilars in Emerging Economies, Marketed Biosimilar Products, Reliance Life Sciences, 2012 36

Table 14: Biosimilars in Emerging Economies, Pipeline Molecules, Reliance Life Sciences, 2012 37

Table 15: Biosimilars in Emerging Economies, Marketed Biosimilar Products, Wockhardt, 2012 38

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,511.33 +9.68 0.06%
S&P 500 1,878.02 +2.63 0.14%
NASDAQ 4,145.2670 +18.30 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs